Please use this identifier to cite or link to this item: http://repositorio.ufla.br/jspui/handle/1/32525
metadata.artigo.dc.title: Can inhibitors of snake venom phospholipases a2 lead to new insights into anti-inflammatory therapy in humans? A theoretical study
metadata.artigo.dc.creator: Sales, Thaís A.
Marcussi, Silvana
Cunha, Elaine F. F. da
Kuca, Kamil
Ramalho, Teodorico C.
metadata.artigo.dc.subject: Snake venom
Anti-Inflammatory therapy
Vanillic acid
Veneno de cobra
Terapia Anti-Inflamatória
Ácido vanílico
metadata.artigo.dc.publisher: MDPI
metadata.artigo.dc.date.issued: 2017
metadata.artigo.dc.identifier.citation: SALES, T. A. et al. Can inhibitors of snake venom phospholipases a2 lead to new insights into anti-inflammatory therapy in humans? A theoretical study. [S. l.], v. 9, n. 11, p. 1-14, 2017. doi: 10.3390/toxins9110341.
metadata.artigo.dc.description.abstract: Human phospholipase A2 (hPLA2) of the IIA group (HGIIA) catalyzes the hydrolysis of membrane phospholipids, producing arachidonic acid and originating potent inflammatory mediators. Therefore, molecules that can inhibit this enzyme are a source of potential anti-inflammatory drugs, with different action mechanisms of known anti-inflammatory agents. For the study and development of new anti-inflammatory drugs with this action mechanism, snake venom PLA2 (svPLA2) can be employed, since the svPLA2 has high similarity with the human PLA2 HGIIA. Despite the high similarity between these secretory PLA2s, it is still not clear if these toxins can really be employed as an experimental model to predict the interactions that occur with the human PLA2 HGIIA and its inhibitors. Thus, the present study aims to compare and evaluate, by means of theoretical calculations, docking and molecular dynamics simulations, as well as experimental studies, the interactions of human PLA2 HGIIA and two svPLA2s, Bothrops toxin II and Crotoxin B (BthTX-II and CB, respectively). Our theoretical findings corroborate experimental data and point out that the human PLA2 HGIIA and svPLA2 BthTX-II lead to similar interactions with the studied compounds. From our results, the svPLA2 BthTX-II can be used as an experimental model for the development of anti-inflammatory drugs for therapy in humans.
metadata.artigo.dc.identifier.uri: https://www.mdpi.com/2072-6651/9/11/341
http://repositorio.ufla.br/jspui/handle/1/32525
metadata.artigo.dc.language: en_US
Appears in Collections:DQI - Artigos publicados em periódicos

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.